These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4404669)

  • 21. Inhibition of the acute inflammatory response by interferon inducers.
    Koltai M; Méos E
    Nature; 1973 Apr; 242(5399):525-6. PubMed ID: 4735607
    [No Abstract]   [Full Text] [Related]  

  • 22. Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus.
    Stringfellow DA; Kern ER; Kelsey DK; Glasgow LA
    J Infect Dis; 1977 Apr; 135(4):540-51. PubMed ID: 192804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of glucose transport of Ehrlich ascites tumour cell by interferon inducers.
    Fung KP; Ng SW; Ha DK; Choy YM
    Chemotherapy; 1986; 32(5):458-63. PubMed ID: 2428563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essentially pure murine interferon-alpha/beta primes poly rI:rC and Sendai virus-induced interferon production in mice.
    Rosztóczy I; Megyeri K
    J Biol Regul Homeost Agents; 1989; 3(1):35-8. PubMed ID: 2472043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of mice with polyinosinic-polycytidilic polyribonucleotide reduces T-cell involvement in a localized inflammatory response to vaccinia virus challenge.
    Korngold R; Doherty PC
    J Virol; 1985 Feb; 53(2):489-94. PubMed ID: 2578572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral effects of double-stranded RNA from rice dwarf virus on infection of mice with western equine encephalitis virus.
    Takehara M
    Microbiol Immunol; 1977; 21(6):309-15. PubMed ID: 333233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon in experimental viral infections in mice: tissue interferon levels resulting from the virus infection and from exogenous interferon therapy.
    Heremans H; Billiau A; De Somer P
    Infect Immun; 1980 Nov; 30(2):513-22. PubMed ID: 6160109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of prophylactic effect of statolon against mengovirus in mice.
    Schmidt JP; Pindak FF
    Appl Microbiol; 1968 Mar; 16(3):468-9. PubMed ID: 4297000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo hyporesponsiveness induced by Sendai virus in CFLP mice.
    Mécs I; Koltai M
    Acta Virol; 1982 Sep; 26(5):346-52. PubMed ID: 6183956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression of humoral immunity to sheep erythrocytes in vitro by Friend virus leukemic spleen cells: induction of resistance by statolon.
    Weislow OS; Wheelock EF
    J Immunol; 1975 Jan; 114(1 Pt 1):211-5. PubMed ID: 1089711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid.
    Stringfellow DA
    Antimicrob Agents Chemother; 1977 Jun; 11(6):984-92. PubMed ID: 879763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of the effectiveness of the interferon inducers, poly(I) : poly(C) and GSS (gossypol-beta-aminoethylsodium sulfate), in combination with a specific vaccine in experimental infection with the human acute encephalomyelitis virus].
    Vagabov RM; Barinskiĭ IF; Dushanbieva S
    Vopr Virusol; 1980; (3):334-7. PubMed ID: 7434726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents.
    Stringfellow DA; Glasgow LA
    Infect Immun; 1972 Nov; 6(5):743-7. PubMed ID: 4344367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis.
    Padalko E; Nuyens D; De Palma A; Verbeken E; Aerts JL; De Clercq E; Carmeliet P; Neyts J
    Antimicrob Agents Chemother; 2004 Jan; 48(1):267-74. PubMed ID: 14693549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].
    Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
    No To Shinkei; 1982 Mar; 34(3):267-73. PubMed ID: 7093065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice.
    Wong JP; Saravolac EG; Sabuda D; Levy HB; Kende M
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2574-6. PubMed ID: 8585749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral activity of BL-3849A, a low-molecular-weight oral interferon inducer.
    Kern ER; Hamilton JR; Overall JC; Glasgow LA
    Antimicrob Agents Chemother; 1976 Oct; 10(4):691-6. PubMed ID: 185953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further studies on the relative antiviral efficacies of interferons induced by poly I:C and Mengo virus.
    Campbell JB
    Can J Microbiol; 1976 May; 22(5):712-8. PubMed ID: 179687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral activity of an ether-extracted nonviable preparation of Brucella abortus.
    Youngner JS; Keleti G; Feingold DS
    Infect Immun; 1974 Dec; 10(6):1202-6. PubMed ID: 4373393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly I:CLC induction of the interferon system in mice: an initial study of four detection methods.
    Poast J; Seidel HM; Hendricks MD; Haslam JA; Levy HB; Baron S
    J Interferon Cytokine Res; 2002 Oct; 22(10):1035-40. PubMed ID: 12433283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.